Yirui Biological announced that the company's closing prices on November 25, 26, and 27, 2024, consecutively exceeded a deviation value of 30% for 3 trading days, indicating abnormal fluctuations in stock trading. Upon verification, there is no need to correct or supplement the information disclosed by the company earlier; the company's recent operational situation and internal and external operational environment have not undergone significant changes; the company has not found any recent public media reports that may have had a significant impact on the trading price of the company's stocks with undisclosed major information; the company, major shareholder, and actual controller have no undisclosed major issues to disclose, or major issues in the planning stage; during the abnormal stock movement period, the company's major shareholder and actual controller did not engage in buying or selling the company's stocks.